Cargando…

Role of Type2 Inflammatory Biomarkers in Chronic Obstructive Pulmonary Disease

Airway inflammation in chronic obstructive pulmonary disease (COPD) is typically thought to be driven by Type1 immune responses, while Type2 inflammation appears to be present in definite proportions in the stable state and during exacerbations. In fact, some COPD patients showed gene expression of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oishi, Keiji, Matsunaga, Kazuto, Shirai, Toshihiro, Hirai, Keita, Gon, Yasuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464674/ https://www.ncbi.nlm.nih.gov/pubmed/32824775 http://dx.doi.org/10.3390/jcm9082670

Ejemplares similares

Comorbid Conditions in Chronic Obstructive Pulmonary Disease: Potential Therapeutic Targets for Unmet Needs
por: Matsunaga, Kazuto, et al.
Publicado: (2020)

Computed Tomography Lung Density Analysis: An Imaging Biomarker Predicting Physical Inactivity in Chronic Obstructive Pulmonary Disease: A Pilot Study
por: Murata, Yoriyuki, et al.
Publicado: (2023)

Impact of Frailty on Hippocampal Volume in Patients with Chronic Obstructive Pulmonary Disease
por: Takahashi, Shun, et al.
Publicado: (2021)

Measurement of Blood Eosinophils in Asthma and Chronic Obstructive Pulmonary Disease
por: Hirano, Tsunahiko, et al.
Publicado: (2022)

Three‐step algorithm for biological therapy targeted IgE and IL‐5 in severe asthma
por: Oishi, Keiji, et al.
Publicado: (2018)

Utility of the Shortness of Breath in Daily Activities Questionnaire (SOBDA-Q) to Detect Sedentary Behavior in Patients with Chronic Obstructive Pulmonary Disease (COPD)
por: Yamaji, Yoshikazu, et al.
Publicado: (2023)

Inflammatory parameters and pulmonary biomarkers in smokers with and without chronic obstructive pulmonary disease (COPD)
por: Andreeva, Elena, et al.
Publicado: (2021)

Iron-Regulated Reactive Oxygen Species Production and Programmed Cell Death in Chronic Obstructive Pulmonary Disease
por: Mizumura, Kenji, et al.
Publicado: (2021)

Improvement of Airflow Limitation by Fluticasone Propionate/Salmeterol in Chronic Obstructive Pulmonary Disease: What is the Specific Marker?
por: Akamatsu, Keiichiro, et al.
Publicado: (2011)

Time To Revise COPD Treatment Algorithm
por: Matsunaga, Kazuto, et al.
Publicado: (2019)

Current Chronic Obstructive Pulmonary Disease Treatment Status in Asia: A Position Statement of the Asian Pacific Society of Respirology
por: Choi, Joon Young, et al.
Publicado: (2022)

Reassessing the Role of Eosinophils as a Biomarker in Chronic Obstructive Pulmonary Disease
por: Tinè, Mariaenrica, et al.
Publicado: (2019)

Neural Network Approach to Investigating the Importance of Test Items for Predicting Physical Activity in Chronic Obstructive Pulmonary Disease
por: Nakahara, Yoshiki, et al.
Publicado: (2023)

The Combined Value of Type2 Inflammatory Markers in Chronic Obstructive Pulmonary Disease
por: Liu, Yunhuan, et al.
Publicado: (2022)

Effects of pharmacologic treatment based on airflow limitation and breathlessness on daily physical activity in patients with chronic obstructive pulmonary disease
por: Minakata, Yoshiaki, et al.
Publicado: (2015)

Important Biomarkers that Play a Role in the Chronic Obstructive Pulmonary Disease Process
por: Avci, Emre, et al.
Publicado: (2018)

Feasibility of Discontinuing Biologics in Severe Asthma: An Algorithmic Approach
por: Hamada, Kazuki, et al.
Publicado: (2021)

Role of T-lymphocytes and pro-inflammatory mediators in the pathogenesis of chronic obstructive pulmonary disease
por: Gadgil, Aneal, et al.
Publicado: (2008)

Adipokine CTRP-5 as a Potential Novel Inflammatory Biomarker in Chronic Obstructive Pulmonary Disease
por: Li, Diandian, et al.
Publicado: (2015)

Bronchoalveolar pH and inflammatory biomarkers in patients with acute exacerbation of chronic obstructive pulmonary disease
por: Lozo Vukovac, Emilija, et al.
Publicado: (2018)

Biomarkers in chronic obstructive pulmonary disease: confusing or useful?
por: Stockley, Robert A
Publicado: (2014)

Fractal Analysis of Lung Structure in Chronic Obstructive Pulmonary Disease
por: Tanabe, Naoya, et al.
Publicado: (2020)

Biomarkers of Right Ventricular–Pulmonary Coupling in Chronic Obstructive Pulmonary Disease
por: Mehmood, Muddassir
Publicado: (2019)

Transcriptome-based Signatures: The Future Biomarkers in Obstructive Pulmonary Diseases Such as Asthma and Chronic Obstructive Pulmonary Disease?
por: van den Berge, Maarten, et al.
Publicado: (2021)

CC16 as an Inflammatory Biomarker in Induced Sputum Reflects Chronic Obstructive Pulmonary Disease (COPD) Severity
por: Chen, Mengjie, et al.
Publicado: (2023)

Practical Recommendations for a Selection of Inhaled Corticosteroids in COPD: A Composite ICO Chart
por: Oishi, Keiji, et al.
Publicado: (2023)

Assessment of Some Inflammatory Biomarkers as Predictors of Outcome of Acute Respiratory Failure on Top of Chronic Obstructive Pulmonary Disease and Evaluation of the Role of Bacteria
por: Shafiek, Hanaa Ahmed, et al.
Publicado: (2012)

Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease
por: Duvoix, Annelyse, et al.
Publicado: (2013)

Cardiac biomarkers of prognostic importance in chronic obstructive pulmonary disease
por: Nilsson, Ulf, et al.
Publicado: (2020)

Biomarker-based clustering of patients with chronic obstructive pulmonary disease
por: Vanfleteren, Lowie E.G.W., et al.
Publicado: (2023)

The Ongoing Quest for Predictive Biomarkers in Chronic Obstructive Pulmonary Disease
por: Regard, Lucile, et al.
Publicado: (2023)

The role of microparticles in chronic obstructive pulmonary disease
por: Takahashi, Toru, et al.
Publicado: (2014)

The Role of Revefenacin in Chronic Obstructive Pulmonary Disease
por: Maqsood, Muhammad Haisum, et al.
Publicado: (2019)

Role of Proteases in Chronic Obstructive Pulmonary Disease
por: Pandey, Kailash C., et al.
Publicado: (2017)

The effects of pulmonary rehabilitation on inflammatory biomarkers in patients with chronic obstructive pulmonary disease: Protocol for a systematic review and meta-analysis
por: Newman, Anastasia N. L., et al.
Publicado: (2023)

Compartment differences of inflammatory activity in chronic obstructive pulmonary disease
por: Ji, Jie, et al.
Publicado: (2014)

The Heterogeneity of Inflammatory Response and Emphysema in Chronic Obstructive Pulmonary Disease
por: Xu, Xia, et al.
Publicado: (2021)

The role of serum surfactant protein D as a biomarker of exacerbation of chronic obstructive pulmonary disease
por: Zien Alaabden, Alaa, et al.
Publicado: (2016)

Low-dose Fluticasone Propionate in Combination With Salmeterol in Patients With Chronic Obstructive Pulmonary Disease
por: Yasui, Hideki, et al.
Publicado: (2018)

Association Between the Inflammatory Biomarkers and Left Ventricular Systolic Dysfunction in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease
por: Andrijevic, Ljiljana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fup8iive3h331gh200ulk14iot